This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Thermo Fisher (TMO)

Tipranks - Wed Jun 3, 8:12AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Amgen (AMGN) and Thermo Fisher (TMO).

Claim 55% Off TipRanks

Amgen (AMGN)

Bernstein analyst Courtney Breen maintained a Hold rating on Amgen yesterday. The company’s shares closed last Monday at $329.13.

According to TipRanks.com, Breen is a 5-star analyst with an average return of 19.7% and a 88.5% success rate. Breen covers the Healthcare sector, focusing on stocks such as Bristol-Myers Squibb, Merck & Company, and Gilead Sciences. ;'>

Amgen has an analyst consensus of Moderate Buy, with a price target consensus of $366.26, representing a 9.9% upside. In a report issued on May 20, TipRanks – DeepSeek also downgraded the stock to Hold with a $349.00 price target.

See the top stocks recommended by analysts >>

Thermo Fisher (TMO)

Bank of America Securities analyst Michael Ryskin maintained a Buy rating on Thermo Fisher today and set a price target of $630.00. The company’s shares closed last Monday at $494.04, close to its 52-week low of $493.30.

According to TipRanks.com, Ryskin is a 3-star analyst with an average return of 2.2% and a 51.5% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as West Pharmaceutical Services, Caris Life Sciences, Inc., and Tempus AI, Inc. Class A. ;'>

Currently, the analyst consensus on Thermo Fisher is a Strong Buy with an average price target of $608.38, representing a 24.2% upside. In a report released yesterday, Wolfe Research also initiated coverage with a Buy rating on the stock with a $535.00 price target.

Read More on AMGN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.